Nileena Velappan

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

JMIR public health and surveillance

PloS one

mAbs

ImmunoTargets and therapy

Los Alamos National Laboratory

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Los Alamos National Laboratory Jan 01 2017

United States

Research Technologist III :: B-10: Biosecurity and Public Health

Publications

Nileena Velappan, Sergei S Biryukov, Nathaniel O Rill, Christopher P Klimko, Raysa Rosario-Acevedo, Jennifer L Shoe, Melissa Hunter, Jennifer L Dankmeyer, David P Fetterer, Daniel H Bedinger, Mary E Phipps, Austin J Watt, Rebecca J Abergel, Armand Dichosa, Stosh A Kozimor, Christopher K Cote, Antonietta Maria Lillo
Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potential. PloS one 19 (7) (2024)
Nileena Velappan, Sergei S Biryukov, Nathaniel O Rill, Christopher P Klimko, Raysa Rosario-Acevedo, Jennifer L Shoe, Melissa Hunter, Jennifer L Dankmeyer, David P Fetterer, Daniel H Bedinger, Mary E Phipps, Austin J Watt, Rebecca J Abergel, Armand Dichosa, Stosh A Kozimor, Christopher K Cote, Antonietta Maria Lillo
Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potential. PloS one 19 (7) (2024)
Nileena Velappan, Hau B Nguyen, Sofiya Micheva-Viteva, Daniel Bedinger, Chunyan Ye, Betty Mangadu, Austin J Watts, Robert J Meagher, Steven Bradfute, Bin Hu, Geoffrey S Waldo, Antonietta M Lillo
Healthy humans can be a source of antibodies countering COVID-19. Bioengineered 13 (5) (2022)
Nileena Velappan, Sofiya Micheva-Viteva, Samantha H Adikari, Geoffrey S Waldo, Antonietta M Lillo, Andrew Raymon Morton Bradbury
Selection and verification of antibodies against the cytoplasmic domain of M2 of influenza, a transmembrane protein. mAbs 12 (1) (2021)
Nidhi Parikh, Ashlynn Rae Daughton, William Earl Rosenberger, Derek Jacob Aberle, Maneesha Elizabeth Chitanvis, Forest Michael Altherr, Nileena Velappan, Geoffrey Fairchild, Alina Deshpande
Improving Detection of Disease Re-emergence Using a Web-Based Tool (RED Alert): Design and Case Analysis Study. JMIR public health and surveillance 7 (1) (2021)
Antonietta Maria Lillo, Nileena Velappan, Julia M Kelliher, Austin J Watt, Samuel P Merriman, Grace Vuyisich, Laura M Lilley, Kent E Coombs, Tara Mastren, Munehiro Teshima, Benjamin W Stein, Gregory L Wagner, Srinivas Iyer, Andrew Raymon Morton Bradbury, Jennifer Foster Harris, Armand E K Dichosa, Stosh A Kozimor
Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications. ImmunoTargets and therapy 9 (2020)
Nileena Velappan, Avanika Mahajan, Leslie Naranjo, Priyanka Velappan, Nasim Andrews, Nicholas Tiee, Subhendu Chakraborti, Colin F Hemez, Tiziano Gaiotto, Bridget S Wilson, Andrew Bradbury
Selection and characterization of FcεRI phospho-ITAM specific antibodies. mAbs 11 (7) (2019)
Nileena Velappan, Ashlynn Rae Daughton, Geoffrey Fairchild, William Earl Rosenberger, Nicholas Generous, Maneesha Elizabeth Chitanvis, Forest Michael Altherr, Lauren A Castro, Reid Priedhorsky, Esteban Luis Abeyta, Leslie A Naranjo, Attelia Dawn Hollander, Grace Vuyisich, Antonietta Maria Lillo, Emily Kathryn Cloyd, Ashvini Rajendra Vaidya, Alina Deshpande
Analytics for Investigation of Disease Outbreaks: Web-Based Analytics Facilitating Situational Awareness in Unfolding Disease Outbreaks. JMIR public health and surveillance 5 (1) (2019)

Nileena Velappan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nileena Velappan